Keyword: AstraZeneca

News

Drug Industry Bets on New Blockbusters in 2013

16.01.2013 - Drugmakers are betting that a new wave of medicines for cancer, diabetes, heart disease, multiple sclerosis and hepatitis will shape up as tomorrow's blockbusters in the coming 12...

News

AstraZeneca's New CEO Removes R&D, Commercial Heads

15.01.2013 - AstraZeneca's new chief executive stamped his authority on the struggling drugmaker on Tuesday by removing the heads of research and commercial operations. Pascal Soriot, who took...

News

China to Cut Prices of More than 400 Drugs from February

08.01.2013 - China will cut prices of about 400 drugs for respiratory diseases, fever and pain by up to 20% from February, in a move to make medicines, including some products from Pfizer...

News

US FDA New Drug Approvals Hit 16-Year High in 2012

02.01.2013 - U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars in recent years to...

News

Number of New Drugs Picks Up in Europe and U.S.

19.12.2012 - The number of new medicines approved or pending approval is on the rise on both sides of the Atlantic, painting an encouraging picture for the global drugs industry as it emerges...

News

Top EU Court Upholds AstraZeneca Fine Over Ulcer Drug

06.12.2012 - The European Union's highest court has upheld a €52.5 million ($69 million) antitrust fine levied against AstraZeneca for blocking the entry of cheaper rivals to its then...

News

Drug Industry Treading Water on R&D Productivity

04.12.2012 - Drug companies are becoming more efficient in hunting for new treatments, though this has yet to be reflected in improved investment returns, according to a report on Tuesday. Low...

News

EU Doctors Turn to Last-Ditch Antibiotics as Resistance Grows

16.11.2012 - Doctors are increasingly having to turn to last-ditch antibiotics due to growing drug-resistant superbug infections in Europe, EU health officials said on Friday. The problem is...